FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s – The New York Times

  1. FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s  The New York Times
  2. FDA approves a second Alzheimer’s drug, Eli Lilly’s Kisunla  The Associated Press

Go to News Source